Role of nitric oxide in methamphetamine neurotoxicity: Protection by 7- nitroindazole, an inhibitor of neuronal nitric oxide synthase

Journal of Neurochemistry

Volumn 67, Issue 6, 1996, Pages 2443-2450

  Di Monte, Donato A ^a   Royland, Joyce E ^a   Jakowec, Michael W ^a   Langston, J William ^a  

^a PARKINSON S INSTITUTE   (United States)

Author keywords

7 Nitroindazole; Dopamine; Methamphetamine; Neuroprotection; Nitric oxide; Parkinson's disease

Indexed keywords

7 NITROINDAZOLE; METHAMPHETAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; ENZYME INHIBITION; MALE; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANIMALIA;

EID: 0029805318     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67062443.x     Document Type: Article

References (34)

1. Ali S. F., Newport G. D., Holson R. R., Slikker W. Jr., and Bowyer J. F. (1994) Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res. 658, 33-38.
2. Askew B. M. (1962) Hyperpyrexia as a contributing factor in the toxicity of amphetamine in aggregated mice. Br. J. Pharmacol. 19, 245-257.
3. Babbedge R. C., Bland-Ward P. A., Hart S. L., and Moore P. K. (1993) Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br. J. Pharmacol. 110, 225-228.
4. Bowyer J. F., Tank A. W., Newport G. D., Slikker W. Jr., Ali S. F., and Holson R. R. (1992) The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J. Pharmacol. Exp. Ther. 260, 817-824.
5. Bowyer J. F., Davies D. L., Schmued L., Broening H. W., Newport G. D., Slikker W. Jr., and Holson R. R. (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268, 1571-1580.
6. Bowyer, J. F., Clausing P.. Gough B., Slikker W. Jr., and Holson R. R. (1995) Nitric oxide regulation of methamphetamine-induced dopamine release in caudate/putamen. Brain Res. 699, 62-70.
7. Bredt D. S., Glatt C. E., Hwang P. M., Fotuhi M., Dawson T. M., and Snyder S. H. (1991) Nitric oxide synthase protein and NA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 7, 615-624.
8. Cerruti C., Sheng P., Ladenheim B., Epstein C. J., and Cadet J.-L. (1995) Involvement of oxidative and L-arginine-NO pathways in the neurotoxicity of drugs of abuse in vitro. Clin. Exp. Pharmacol. Physiol. 22, 381-382.
9. + elimination in the mouse striatum. J. Pharmacol. Exp. Ther. 267, 1515-1520.
10. Chan P., Di Monte D. A., Luo J.-J., DeLanney L. E., Irwin I., and Langston J. W. (1994) Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity. J. Neurochem. 62, 2484-2487.
11. Cleeter M. W., Cooper J. M., Darley-Usmar V. M., Moncada S., and Schapira A. H. (1994) Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett. 345, 50-54.
12. Dawson V. L., Dawson T. M., London E. D., Bredt D. S., and Snyder S. H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88, 6368-6371.
13. Graham D. G., Tiffany S. M., Bell W. R. Jr., and Gutknecht W. F. (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14, 644-653.
14. 3H]-dopamine from striatal slices. Neuroreport 3, 409-412.
15. Kilpatrick I. C., Jones M. W., and Phillipson O. T. (1986) A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing coulometric detection and minimal sample preparation. J. Neurochem. 46, 1865-1876.
16. Lipton S. A., Choi Y.-B., Pan Z.-H., Lei S. Z., Chen H.-S. V., Sucher N. J., Loscalzo J., Singel D. J., and Stamler J. S. (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364, 626-632.
17. Lizasoain V. M., Moro M. A., Knowles R. G., Darley-Usmar V., and Moncada S. (1996) Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem. J. 314, 877-880.
18. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
19. Miller D. B. and O'Callaghan J. P. (1994) Environment-, drug-and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6 mouse. J. Pharmacol. Exp. Ther. 270, 252-260.
20. O'Dell S. J., Weihmuller F. B., and Marshall J. F. (1991) Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res. 564, 256-260.
21. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V. L., and Dawson T. M. (1996) Role of neuronal nitric oxide in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA 93, 4565-4571.
22. Radi R., Rodriguez M., Castro L., and Teilen R. (1994) Inhibition of mitochondrial electron transport by peroxynitrite. Arch. Biochem. Biophys. 308, 89-95.
23. Ricaurte G. A., Guillery R. W., Seiden L. S., Schuster C. R., and Moore R. Y. (1982) Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235, 93-103.
24. Ricaurte G, A., Langston J. W., DeLanney L. E., Irwin I., Peroutka S. J., and Forno L. S. (1986) Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment. Brain Res. 376, 117-124.
25. Rose S., Hindmarsh J. G., and Jenner P. (1994) Inhibition of nitric oxide synthase enhances NMDA-evoked dopamine release in rat striatum in vivo. Br. J. Pharmacol. 111, 59P.
26. Schmidt C. J., Ritter J. K., Sonsalla P. K., Hanson G. R., and Gibb J. W. (1985) Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233, 539-544.
27. Schulz J. B., Matthews R. T., Muqit M. M. K., Browne S. E., and Beal M. F. (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64, 936-939.
28. Seiden L. S. and Vosmer G. A. (1984) Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine. Pharmacol. Biochem. Behav. 21, 29-31.
29. Sonsalla P. K., Nicklas W. J., and Heikkila R. E. (1989) Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 245, 398-400.
30. Sonsalla P. K., Riordan D. E., and Heikkila R. E. (1991) Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J. Pharmacol Exp. Ther. 256, 506-512.
31. Sonsalla P. K., Zeevalk G. D., Manzino L., Giovanni A., and Nicklas W. J. (1992) MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats. J. Neurochem. 58, 1979-1982.
32. Stephans S. E. and Yamamoto B. K. (1994) Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 17, 203-209.
33. Turrens J. F. and Boveris A. (1980) Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 191, 421-427.
34. + neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349, 414-418.